Philip N. Kaplan

Philip N. Kaplan discloses dealings in 3 companies, chiefly Vitalstream Holdings Inc, Internap Corp and Nextgen Healthcare, Inc. In total, 46 filings cover trades dated from 16 March 2006 to 30 November 2009.

On the open market, the record shows 8 purchases worth €78k and 30 sales worth €2.3M. The net balance comes to €2.2M on the selling side. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 4 share grants. Since January 2009: 8 purchases and no sales on the market.

In size, the median ticket on the buying side is €5,818.

The newest entry dates from 1 December 2009: an open-market purchase of €7,759, in Nextgen Healthcare, Inc. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.